Literature DB >> 33466353

Incidence of Antibiotic Treatment Failure in Patients with Nursing Home-Acquired Pneumonia and Community Acquired Pneumonia.

Mariana Lopes1, Gonçalo Alves Silva1, Rui Filipe Nogueira2, Daniela Marado3, João Gonçalves3, Carlos Athayde3, Dilva Silva3, Ana Figueiredo3, Jorge Fortuna3, Armando Carvalho3.   

Abstract

PURPOSE: Nursing home-acquired pneumonia (NHAP) patients are at higher risk of multi-drug resistant infection (MDR) than those with community-acquired pneumonia (CAP). Recent evidence suggests a single risk factor for MDR does not accurately predict the need for broad-spectrum antibiotics. The goal of this study was to compare the rate antibiotic failure between NHAP and CAP patients.
METHODS: Demographic characteristics, co-morbidities, clinical and laboratory variables, antibiotic therapy, and mortality data were collected retrospectively for all patients with pneumonia admitted to an Internal Medicine Service between April 2017 and April 2018.
RESULTS: In total, 313 of 556 patients had CAP and 243 had NHAP. NHAP patients were older, and were more likely to be dependent, to have recent antibiotic use, and to experience treatment failure (odds ratio (OR) 1.583; 95% CI 1.102-2.276; p = 0.013). In multivariate analysis, patient's origin did not predict treatment failure (OR 1.083; 95% CI 0.726-1.616; p = 0.696). DISCUSSION: Higher rates of antibiotic failure and mortality in NHAP patients were explained by the presence of other risk factors such as comorbidities, more severe presentation, and age. Admission from a nursing home is not a sufficient condition to start broader-spectrum antibiotics.

Entities:  

Keywords:  antimicrobial drug resistance; community-acquired pneumonia; epidemiology; nursing home-acquired pneumonia; treatment failure

Year:  2021        PMID: 33466353      PMCID: PMC7838805          DOI: 10.3390/idr13010006

Source DB:  PubMed          Journal:  Infect Dis Rep        ISSN: 2036-7430


  38 in total

1.  Outcome of nursing home-acquired pneumonia: derivation and application of a practical model to predict 30 day mortality.

Authors:  B J Naughton; J M Mylotte; A Tayara
Journal:  J Am Geriatr Soc       Date:  2000-10       Impact factor: 5.562

Review 2.  Is healthcare-associated pneumonia a distinct entity needing specific therapy?

Authors:  Santiago Ewig; Tobias Welte; Antoni Torres
Journal:  Curr Opin Infect Dis       Date:  2012-04       Impact factor: 4.915

3.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2005-02-15       Impact factor: 21.405

4.  Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department.

Authors:  Andrew F Shorr; Marya D Zilberberg; Richard Reichley; Jason Kan; Alex Hoban; Justin Hoffman; Scott T Micek; Marin H Kollef
Journal:  Clin Infect Dis       Date:  2011-11-21       Impact factor: 9.079

5.  One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare System.

Authors:  Joe L Hsu; Andrew M Siroka; Mark W Smith; Mark Holodniy; G Umberto Meduri
Journal:  Int J Infect Dis       Date:  2011-03-09       Impact factor: 3.623

6.  Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia.

Authors:  Mario Venditti; Marco Falcone; Salvatore Corrao; Giuseppe Licata; Pietro Serra
Journal:  Ann Intern Med       Date:  2009-01-06       Impact factor: 25.391

7.  Clinical characteristics of nursing home-acquired pneumonia in elderly patients admitted to a Korean teaching hospital.

Authors:  Seong Joo Koh; Jong Hoo Lee
Journal:  Korean J Intern Med       Date:  2015-08-27       Impact factor: 2.884

8.  Prognostic value of severity indicators of nursing-home-acquired pneumonia versus community-acquired pneumonia in elderly patients.

Authors:  Motoi Ugajin; Kenichi Yamaki; Natsuko Hirasawa; Takanori Kobayashi; Takeo Yagi
Journal:  Clin Interv Aging       Date:  2014-02-11       Impact factor: 4.458

9.  Individualizing risk of multidrug-resistant pathogens in community-onset pneumonia.

Authors:  Marco Falcone; Alessandro Russo; Maddalena Giannella; Roberto Cangemi; Maria Gabriella Scarpellini; Giuliano Bertazzoni; José Martínez Alarcón; Gloria Taliani; Paolo Palange; Alessio Farcomeni; Annarita Vestri; Emilio Bouza; Francesco Violi; Mario Venditti
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

10.  Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America.

Authors:  Joshua P Metlay; Grant W Waterer; Ann C Long; Antonio Anzueto; Jan Brozek; Kristina Crothers; Laura A Cooley; Nathan C Dean; Michael J Fine; Scott A Flanders; Marie R Griffin; Mark L Metersky; Daniel M Musher; Marcos I Restrepo; Cynthia G Whitney
Journal:  Am J Respir Crit Care Med       Date:  2019-10-01       Impact factor: 21.405

View more
  2 in total

1.  Risk factor-based analysis of community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia: Microbiological distribution, antibiotic resistance, and clinical outcomes.

Authors:  Hakjun Hyun; Joon Young Song; Jin Gu Yoon; Hye Seong; Ji Yun Noh; Hee Jin Cheong; Woo Joo Kim
Journal:  PLoS One       Date:  2022-06-29       Impact factor: 3.752

2.  Protein C activity as a potential prognostic factor for nursing home-acquired pneumonia.

Authors:  Issei Oi; Isao Ito; Naoya Tanabe; Satoshi Konishi; Nobuyoshi Hamao; Masahiro Shirata; Seiichiro Imai; Yoshiro Yasutomo; Seizo Kadowaki; Hisako Matsumoto; Yu Hidaka; Satoshi Morita; Toyohiro Hirai
Journal:  PLoS One       Date:  2022-10-12       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.